Skip to main content
OpenTrials
Completed

NCT Number: NCT06101732

LIMBO : Breast Reconstruction by Lipomodeling Alone or With Flap: Evaluation in Franche-Comté

The Limbo study is a retrospective descriptive study which aims to establish the current state of breast reconstruction surgery at the Besançon University Hospital and Hôpital Nord Franche-Comté, between October 2017 and December 2021.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases Surgery

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

CHU de besancon

Besançon, 25030, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient who has undergone breast reconstruction using lipomodelling alone or in association with a flap (greater dorsal, DIEP Deep Inferior Epigastric Perforator flap or TRAM Tranverse Rectus Abdominis Myocutaneous Flap), since October 2017.

Patient whose follow-up in plastic surgery is considered completed (final result obtained, patient lost to follow-up or not wishing to continue) at the time of data collection.

Exclusion criteria

  • Patient under 18 at first consultation
  • Opposition of the patient to the collection of her data

Treatment and study plan

Primary outcomes

  1. number of surgical procedures according to the type of breast reconstruction using lipomodelling alone or in combination with a flap

    Time frame: Between october 2017 and 2022

    number of surgical procedures

Secondary outcomes

  1. description of patients' age

    Time frame: at inclusion

    patient age

  2. description of patients' Body Mass Index

    Time frame: at inclusion

    Body Mass Index

  3. description of patients' menopause status

    Time frame: at the time of data collection

    menopause status

  4. description of patients' smoking status

    Time frame: at inclusion

    smoking status

  5. description of patients' diabetes or other medical condition

    Time frame: at inclusion

  6. description of patients' relevant medical history

    Time frame: at inclusion

    relevant medical history

  7. description of patients' History of breast surgery

    Time frame: at inclusion

    hsitory of breast surgery

  8. description of patients' type of cancer

    Time frame: at inclusion

    cancer histology

  9. description of patients' type of surgical treatment

    Time frame: at inclusion

    type of breast reconstruction using lipomodelling alone or in combination with a flap

  10. description of patients' Type of treatment associated with surgery

    Time frame: at inclusion

    Type of treatment associated with surgery

  11. description of Time elapsed between mastectomy and reconstruction

    Time frame: at inclusion

    number of month between the date of mastectomy and date of reconstruction

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Besancon

Other

Registry information

Official study title

Breast Reconstruction by Lipomodeling Alone or With Flap: Evaluation in Franche-Comté

Acronym: LIMBO

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Oct 26, 2023
Registry last updated
Oct 27, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.